IL2RA and non-small cell lung carcinoma: These proteases also cleave soluble receptors, such as sCD30, sTNF-R1, sTNF-R2, and IL-2Ra, whose levels in plasma were correlated with sPD-L1 concentrations of advanced NSCLC patients (10, 16, 17).